Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activity

被引：0

作者：

P. R. Sternes

L. Brett

J. Phipps

F. Ciccia

T. Kenna

E. de Guzman

K. Zimmermann

M. Morrison

G. Holtmann

E. Klingberg

D. Mauro

C. McIvor

H. Forsblad-d’Elia

M. A. Brown

机构：

[1] Centre for Microbiome Research,Department of Gastroenterology

[2] Queensland University of Technology,School of Biomedical Sciences

[3] Logan Hospital,Department of Precision Medicine

[4] Queensland University of Technology,Centre for Immunology and Infection Control

[5] Università della Campania L. Vanvitelli,School of Chemistry and Molecular Biosciences

[6] Queensland University of Technology,Faculty of Health and Behavioural Sciences

[7] University of Queensland,Department of Rheumatology and Inflammation Research

[8] University of Queensland,Faculty of Life Sciences and Medicine

[9] Sahlgrenska Academy at University of Gothenburg,undefined

[10] Genomics England,undefined

[11] King’s College London,undefined

来源：

Arthritis Research & Therapy | / 24卷

关键词：

Ankylosing spondylitis; Inflammatory Bowel disease; Dysbiosis; Gut;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] Fecal calprotectin is associated with disease activity in patients with ankylosing spondylitis
Duran, Arzu
Kobak, Senol
Sen, Nazime
Aktakka, Seniha
Atabay, Tennur
Orman, Mehmet
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2016, 16 (01) : 71 - 74
[32] Diet, disease activity, and gastrointestinal symptoms in patients with ankylosing spondylitis
Björn Sundström
Solveig Wållberg-Jonsson
Gunnar Johansson
Clinical Rheumatology, 2011, 30 : 71 - 76
[33] Recent progress on the role of gut microbiota in the pathogenesis of inflammatory bowel disease
Yu, Cheng Gong
Huang, Qin
JOURNAL OF DIGESTIVE DISEASES, 2013, 14 (10) : 513 - 517
[34] The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy
Cammarota, Giovanni
Ianiro, Gianluca
Cianci, Rossella
Sibbo, Stefano
Gasbarrini, Antonio
Curro, Diego
PHARMACOLOGY & THERAPEUTICS, 2015, 149 : 191 - 212
[35] Association of inflammatory bowel disease with ankylosing spondylitis and rheumatoid arthritis: A nationwide population-based study
Bae, Jung Min
Choo, Ji Yoon
Kim, Ki-Jo
Park, Kyung-Su
MODERN RHEUMATOLOGY, 2017, 27 (03) : 435 - 440
[36] Regulation mechanisms of disulfidptosis-related genes in ankylosing spondylitis and inflammatory bowel disease
Li, Lin
Fang, Haixin
Li, Fuzhen
Xie, Kunpeng
Zhou, Pengyi
Zhu, Haiyan
Jin, Xuemin
Song, Ruifeng
Yang, Peizeng
Du, Liping
FRONTIERS IN IMMUNOLOGY, 2024, 15
[37] Exploring the Connections: Autophagy, Gut Microbiota, and Inflammatory Bowel Disease Pathogenesis
Subramanian, Arunkumar
Afrarahamed, J.
Tamilanban, T.
Kumarasamy, Vinoth
Begum, M. Yasmin
Sekar, Mahendran
Subramaniyan, Vetriselvan
Wong, Ling Shing
Al Fatease, Adel
JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 10453 - 10470
[38] Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission
Pisani, Anthea
Rausch, Philipp
Bang, Corinna
Ellul, Sarah
Tabone, Trevor
Cordina, Claire Marantidis
Zahra, Graziella
Franke, Andre
Ellul, Pierre
MICROBIOLOGY SPECTRUM, 2022, 10 (03):
[39] Increased Risk of Inflammatory Bowel Disease Among Patients With Ankylosing Spondylitis: A 13-Year Population-Based Cohort Study
Wang, Shuya
Tsou, Hsi-Kai
Chiou, Jeng-Yuan
Wang, Yu-Hsun
Zhang, Zhiyi
Wei, James Cheng-Chung
FRONTIERS IN IMMUNOLOGY, 2020, 11
[40] Do Anti-TNF Agents Increase the Risk of Inflammatory Bowel Disease Evolution in Patients with Ankylosing Spondylitis? Real Life Data
Cansu, Dondu Uskudar
Teke, Hava Uskudar
Temel, Tuncer
Erturk, Adem
Kahraman, Osman
Korkmaz, Cengiz
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2019, 111 (03) : 262 - 269

← 1 2 3 4 5 →